The most commonly reported side effects of cytarabine include febrile neutropenia, off label use, and pyrexia, based on 63,073 FDA adverse event reports from 2004 to 2025. 4.8% of reports found the drug to be ineffective.
Percentages show how often each reaction appears relative to total reports for cytarabine.
1
Febrile Neutropenia11.4%7,206
2
Off Label Use8.0%5,061
3
Pyrexia5.7%3,617
4
Neutropenia4.9%3,085
5
Drug Ineffective4.8%3,030
6
Disease Progression4.2%2,662
7
Thrombocytopenia4.0%2,554
8
Sepsis4.0%2,522
9
Myelosuppression3.5%2,195
10
Pneumonia3.3%2,062
11
Death3.1%1,968
12
Pancytopenia2.9%1,809
13
Product Use In Unapproved Indication2.8%1,782
14
Anaemia2.6%1,624
15
Septic Shock2.6%1,614
These are voluntary reports and do not establish that cytarabine caused these reactions.
Report severity
97.1%Serious61,260 reports
40.7%Hospitalizations25,672 reports
22.8%Fatal14,408 reports
Seriousness is determined by the reporter, not by OpenClaim.
Cytarabine drug interactions
Other drugs that appear in adverse event reports alongside cytarabine. Drugs flagged as a suspected cause appear in the first column. Drugs taken at the same time but not suspected appear in the second.
Also suspected
1
Methotrexate35.7%22,541
2
Vincristine-sulfate33.3%21,002
3
Cyclophosphamide31.0%19,583
4
Dexamethasone25.3%15,930
5
Etoposide21.9%13,803
6
Doxorubicin-hydrochloride21.2%13,361
7
Rituximab19.8%12,468
8
Daunorubicin18.2%11,487
9
Prednisone14.0%8,829
10
Pegaspargase9.3%5,869
11
Mercaptopurine9.0%5,683
12
Cisplatin8.9%5,626
13
Fludarabine-phosphate7.6%4,772
14
Idarubicin-hydrochloride7.3%4,576
15
Hydrocortisone6.6%4,154
Taken alongside
1
Dexamethasone7.1%4,488
2
Methotrexate6.1%3,876
3
Cyclophosphamide5.4%3,432
4
Acyclovir5.2%3,306
5
Vincristine-sulfate5.2%3,260
6
Ondansetron5.0%3,161
7
Sulfamethoxazole4.6%2,922
8
Acetaminophen4.5%2,836
9
Trimethoprim4.0%2,545
10
Etoposide3.9%2,455
11
Fluconazole3.3%2,086
12
Doxorubicin-hydrochloride3.3%2,051
13
Allopurinol3.1%1,982
14
Daunorubicin2.9%1,804
15
Prednisone2.8%1,769
Co-occurrence in adverse event reports does not establish a drug interaction. Patients often take multiple medications, and these lists reflect prescribing patterns rather than causal relationships. Consult a healthcare provider about potential drug interactions.
Who reports cytarabine side effects
34.3% of cytarabine adverse event reports involve female patients and 47.2% involve male patients. The largest age group is adult at 54%. These figures reflect who reports side effects, not underlying risk.
Sex
Female34.3%
Male47.2%
Unknown18.4%
Age group
< 22.7%
2–1114.8%
12–179.3%
18–6454.4%
65+18.9%
What is cytarabine used for
Conditions and purposes for which patients were taking cytarabine when the adverse event was reported.
5q Minus SyndromeAbdominal LymphadenopathyAcquired Immunodeficiency SyndromeAcute Lymphoblastic LeukemiaAcute Biphenotypic LeukaemiaAcute Graft Versus Host DiseaseAcute Kidney InjuryAcute LeukaemiaAcute Leukaemia In RemissionAcute LeukemiaAcute Lymphoblastic LeukaemiaAcute Lymphoblastic Leukemia RecurrentAcute Lymphocytic LeukaemiaAcute Lymphocytic Leukaemia (in Remission)Acute Lymphocytic Leukaemia Recurrent
Showing 15 of 1,066 indications
5Q MINUS SYNDROME
ABDOMINAL LYMPHADENOPATHY
ACQUIRED IMMUNODEFICIENCY SYNDROME
ACUTE LYMPHOBLASTIC LEUKEMIA
ACUTE BIPHENOTYPIC LEUKAEMIA
ACUTE GRAFT VERSUS HOST DISEASE
ACUTE KIDNEY INJURY
ACUTE LEUKAEMIA
ACUTE LEUKAEMIA IN REMISSION
ACUTE LEUKEMIA
ACUTE LYMPHOBLASTIC LEUKAEMIA
ACUTE LYMPHOBLASTIC LEUKEMIA RECURRENT
ACUTE LYMPHOCYTIC LEUKAEMIA
ACUTE LYMPHOCYTIC LEUKAEMIA (IN REMISSION)
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT
ACUTE LYMPHOCYTIC LEUKAEMIA REFRACTORY
ACUTE LYMPHOCYTIC LEUKEMIA
ACUTE MEGAKARYOCYTIC LEUKAEMIA
ACUTE MONOCYTIC LEUKAEMIA
ACUTE MONOCYTIC LEUKAEMIA (IN REMISSION)
ACUTE MYELOBLASTIC LEUKEMIA
ACUTE MYELOID LEUKAEMIA
ACUTE MYELOID LEUKAEMIA (IN REMISSION)
ACUTE MYELOID LEUKAEMIA RECURRENT
ACUTE MYELOID LEUKAEMIA REFRACTORY
ACUTE MYELOID LEUKEMIA
ACUTE MYELOMONOCYTIC LEUKAEMIA
ACUTE PROMYELOCYTIC LEUKAEMIA
ACUTE UNDIFFERENTIATED LEUKAEMIA
ADENOCARCINOMA
ADULT T-CELL LYMPHOMA/LEUKAEMIA
ALK GENE REARRANGEMENT POSITIVE
ALLOGENIC BONE MARROW TRANSPLANTATION THERAPY
ALLOGENIC STEM CELL TRANSPLANTATION
ALVEOLAR RHABDOMYOSARCOMA
AMERICAN TRYPANOSOMIASIS
ANAEMIA
ANAEMIA HAEMOLYTIC AUTOIMMUNE
ANAPLASTIC CHOROID PLEXUS PAPILLOMA
ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES
ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES REFRACTORY
ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES STAGE I
ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES STAGE II
ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES STAGE III
ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES STAGE IV
ANAPLASTIC LARGE-CELL LYMPHOMA
ANAPLASTIC LYMPHOMA KINASE GENE MUTATION
ANGIOCENTRIC LYMPHOMA
ANGIOCENTRIC LYMPHOMA RECURRENT
ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA
ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA STAGE III
ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA STAGE IV
ANGIOMYOLIPOMA
ARNOLD-CHIARI MALFORMATION
ASPARTATE AMINOTRANSFERASE ABNORMAL
ASTHENIA
ATAXIA TELANGIECTASIA
ATYPICAL TERATOID/RHABDOID TUMOUR OF CNS
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME
AUTOLOGOUS BONE MARROW TRANSPLANTATION THERAPY
AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT
Acute bilineal leukaemia
Acute biphenotypic leukaemia
Acute disseminated encephalomyelitis
Acute erythroid leukaemia
Acute graft versus host disease in skin
Acute kidney injury
Acute leukaemia
Acute leukaemia in remission
Acute lymphocytic leukaemia
Acute lymphocytic leukaemia (in remission)
Acute lymphocytic leukaemia recurrent
Acute lymphocytic leukaemia refractory
Acute megakaryocytic leukaemia
Acute monocytic leukaemia
Acute monocytic leukaemia (in remission)
Acute myeloid leukaemia
Acute myeloid leukaemia (in remission)
Acute myeloid leukaemia recurrent
Acute myeloid leukaemia refractory
Acute myelomonocytic leukaemia
Acute promyelocytic leukaemia
Acute undifferentiated leukaemia
Adult T-cell lymphoma/leukaemia
Adult T-cell lymphoma/leukaemia stage III
Adult T-cell lymphoma/leukaemia stage IV
Advanced systemic mastocytosis
Agranulocytosis
Aleukaemic leukaemia
Allogenic stem cell transplantation
Alveolar rhabdomyosarcoma
Anaemia
Anaplastic large cell lymphoma T- and null-cell types
Anaplastic large cell lymphoma T- and null-cell types refractory
Anaplastic large cell lymphoma T- and null-cell types stage II
Anaplastic large-cell lymphoma
Anaplastic lymphoma kinase gene mutation
Angiocentric lymphoma
Angioimmunoblastic T-cell lymphoma
Angioimmunoblastic T-cell lymphoma stage III
Angioimmunoblastic T-cell lymphoma stage IV
Anogenital warts
Antifungal prophylaxis
Antiviral prophylaxis
Aplastic anaemia
Astrocytoma malignant
Ataxia telangiectasia
Atrial fibrillation
Atypical teratoid/rhabdoid tumour of CNS
Autologous bone marrow transplantation therapy
Autologous haematopoietic stem cell transplant
B PRECURSOR TYPE ACUTE LEUKAEMIA
B precursor type acute leukaemia
B-CELL LYMPHOMA
B-CELL LYMPHOMA RECURRENT
B-CELL LYMPHOMA REFRACTORY
B-CELL LYMPHOMA STAGE II
B-CELL LYMPHOMA STAGE III
B-CELL LYMPHOMA STAGE IV
B-CELL PROLYMPHOCYTIC LEUKAEMIA
B-CELL SMALL LYMPHOCYTIC LYMPHOMA
B-CELL TYPE ACUTE LEUKAEMIA
B-cell lymphoma
B-cell lymphoma recurrent
B-cell lymphoma refractory
B-cell lymphoma stage II
B-cell lymphoma stage III
B-cell lymphoma stage IV
B-cell lymphoma unclassifiable
B-cell prolymphocytic leukaemia
B-cell small lymphocytic lymphoma
B-cell type acute leukaemia
BING-NEEL SYNDROME
BLAST CELL CRISIS
BLAST CELL PROLIFERATION
BLAST CRISIS IN MYELOGENOUS LEUKAEMIA
BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASIA
BLOOD STEM CELL HARVEST
BONE MARROW CONDITIONING REGIMEN
BONE MARROW DISORDER
BONE MARROW FAILURE
BONE MARROW TRANSPLANT
BONE PAIN
BONE SARCOMA
BRAF GENE MUTATION
BRAF V600E MUTATION POSITIVE
BRAF gene mutation
BRAIN NEOPLASM
BRAIN NEOPLASM MALIGNANT
BRAIN SARCOMA
BREAST CANCER
BREAST CANCER FEMALE
BREAST CANCER METASTATIC
BREAST CANCER STAGE IV
BREAST SARCOMA
BRONCHOALVEOLAR LAVAGE
BURKITT'S LEUKAEMIA
BURKITT'S LYMPHOMA
BURKITT'S LYMPHOMA STAGE III
BURKITT'S LYMPHOMA STAGE IV
BURKITT^S LEUKAEMIA
BURKITT^S LYMPHOMA
BURKITT^S LYMPHOMA RECURRENT
BURKITT^S LYMPHOMA STAGE II
BURKITT^S LYMPHOMA STAGE III
BURKITT^S LYMPHOMA STAGE IV
Bile duct cancer
Bing-Neel syndrome
Blast cell count increased
Blast cell crisis
Blast crisis in myelogenous leukaemia
Blastic plasmacytoid dendritic cell neoplasia
Blindness
Blood disorder
Bloom syndrome
Bone lesion
Bone marrow conditioning regimen
Bone marrow disorder
Bone marrow infiltration
Bone marrow necrosis
Bone marrow transplant
Bone neoplasm
Brain cancer metastatic
Brain neoplasm malignant
Brain sarcoma
Breast cancer
Breast cancer metastatic
Bronchopulmonary aspergillosis
Burkitt^s leukaemia
Burkitt^s lymphoma
Burkitt^s lymphoma recurrent
Burkitt^s lymphoma refractory
Burkitt^s lymphoma stage I
Burkitt^s lymphoma stage II
Burkitt^s lymphoma stage III
Burkitt^s lymphoma stage IV
CARCINOMA
CASTLEMAN^S DISEASE
CENTRAL NERVOUS SYSTEM LEUKAEMIA
CENTRAL NERVOUS SYSTEM LYMPHOMA
CENTRAL NERVOUS SYSTEM NEOPLASM
CHEMOTHERAPY
CHLOROMA
CHOROID PLEXUS CARCINOMA
CHROMOSOME ANALYSIS ABNORMAL
CHRONIC HEPATITIS B
CHRONIC LEUKAEMIA
CHRONIC LYMPHOCYTIC LEUKAEMIA
CHRONIC LYMPHOCYTIC LEUKAEMIA REFRACTORY
CHRONIC LYMPHOCYTIC LEUKAEMIA STAGE 4
CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION
CHRONIC LYMPHOCYTIC LEUKEMIA
CHRONIC MYELOID LEUKAEMIA
CHRONIC MYELOID LEUKAEMIA RECURRENT
CHRONIC MYELOID LEUKAEMIA TRANSFORMATION
CHRONIC MYELOMONOCYTIC LEUKAEMIA
CHRONIC MYELOMONOCYTIC LEUKEMIA
COLON CANCER
COLORECTAL CANCER
COMPOSITE LYMPHOMA
CONDITION AGGRAVATED
CONGENITAL APLASTIC ANAEMIA
CONGENITAL RETINOBLASTOMA
CORD BLOOD TRANSPLANT THERAPY
CSF TEST ABNORMAL
CSF test abnormal
CUTANEOUS LYMPHOMA
CUTANEOUS T-CELL LYMPHOMA
CYTOGENETIC ABNORMALITY
CYTOGENETIC ANALYSIS ABNORMAL
CYTOMEGALOVIRUS INFECTION
CYTOMEGALOVIRUS TEST POSITIVE
CYTOREDUCTIVE SURGERY
Cardiac neoplasm malignant
Cardiac tamponade
Castleman^s disease
Cauda equina syndrome
Central nervous system immune reconstitution inflammatory response